TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CI

Cigna Corp

Healthcare · Healthcare Plans

275.30$ -0.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios CI
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
16.0 17.1 28.7 25.3 32.1 22.3 18.5 17.7 12.6 12.3 11.2 11.3
0.4 0.5 0.5 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.3
1.9 1.9 2.5 2.3 2.3 1.9 2.3 2.2 1.8 1.8 1.7 1.7
0.6 0.6 0.6 0.5 0.5 0.4 0.5 0.4 0.4 0.4 0.3 0.3
9.5 9.2 10.4 9.5 9.8 8.1 9.2 9.3 8.5 8.1 7.7 8.4
7.8 8.6 10.2 11.8 18.8 8.6 15.5 22.5 10.4 8.7 9.2 8.0
12.8% 11.6% 9.8% 8.5% 5.3% 11.7% 6.4% 4.4% 9.6% 11.5% 10.9% 12.5%
Margins
33.9% 12.9% 12.4% 11.9% 11.2% 10.5% 10.3% 10.5% 10.0% 9.5% 9.3% 11.7%
4.3% 4.4% 4.3% 4.1% 4.0% 3.8% 3.6% 3.5% 3.4% 3.3% 3.4% 3.5%
2.8% 2.6% 1.8% 1.7% 1.3% 1.4% 2.0% 1.9% 2.3% 2.2% 2.3% 2.3%
5.7% 5.2% 4.9% 3.7% 2.2% 3.6% 2.4% 1.5% 2.8% 3.1% 2.8% 3.2%
Returns
11.6% 11.2% 8.8% 9.0% 7.2% 8.4% 12.5% 12.5% 14.7% 14.3% 14.9% 15.1%
3.5% 3.4% 2.4% 2.4% 1.9% 2.2% 3.3% 3.3% 3.9% 3.8% 4.1% 4.1%
Balance Sheet & Debt
22,581 23,108 24,329 25,104 26,914 24,422 22,114 26,439 28,015 23,787 23,860 25,580
2.0 1.9 2.0 2.0 2.1 2.0 1.8 2.1 2.3 2.0 2.0 2.2
30.5% 30.3% 26.9% 26.6% 26.7% 26.3% 26.7% 26.5% 26.5% 26.4% 27.5% 27.1%
0.7 0.7 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.7 0.7
Per Share
17.85 17.53 12.64 13.05 10.80 12.36 17.77 18.71 22.92 22.40 23.80 24.31
639.12 662.89 719.12 767.25 826.54 889.62 901.67 977.33 999.91 1,033.86 1,051.95 1,069.78
153.77 156.92 143.76 145.51 149.59 147.72 142.03 149.97 155.90 156.85 159.75 161.46
36.66 34.76 35.47 28.02 18.42 32.24 21.22 14.71 27.73 31.54 28.99 34.52

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?